Zur Kurzanzeige

AutorBucur, Alexandra Julianadc.contributor.author
Aufnahmedatum2016-03-14T13:40:09Zdc.date.accessioned
In OPARU verfügbar seit2016-03-14T13:40:09Zdc.date.available
Jahr der Erstellung2005dc.date.created
ZusammenfassungMediastinal (thymic) B-cell lymphoma (MBL) is a locally highly aggressive tumor and a distinct subclass of diffuse large B-cell lymphoma. MBL exhibits several characteristic genetic abnormalities; including frequent gains of chromosome 9p and distinct high-level amplifications, with the consensus region 9p24, including the Janus Kinase 2 (Jak2) locus. Janus Kinases (Jaks) and their downstream targets, Signal Transducers and Activators of Transcription (STAT proteins) trigger via activation the cytokine induced signal. In MedB-1, a cell line established from a mediastinal B-cell lymphoma, was found about the double dose of Jak2 DNA compared to autologuos fibroblasts, Jak2 m-RNA expression in MedB-1 cells was also higher than in resting peripheral B cells. The results indicated that Jak2 was not overexpressed at the protein level but highly phosphorylated in MedB-1 cells, its protein turn-over being delayed. STAT5 proteins, downstream partner of Jak2 were highly expressed and phosphorylated at the protein level. MedB-1 also expressed high level of Cyclin D1 one of STAT5 target genes important in cell-cycle regulation. SOCS-1(suppressor of cytokine signaling-1) it is one of the most intensively studied Jak2 negative regulators. The central finding in MedB-1 cells is a biallelic mutation in the SOCS-1 gene, which abrogates SOCS box function of the protein. Ectopic expression of wild-type (wt) SOCS-1 in MedB-1 leads to growth arrest and dramatic reduction of phospho-Jak2 and its downstream partner. Ultimately, the target gene cyclin D1 is repressed in transfectants while Rb1, which is silenced in MedB-1, is induced. In conclusion, in MedB-1, the action of phospho-Jak2 is sustained due to defective SOCS-1.dc.description.abstract
Spracheendc.language.iso
Verbreitende StelleUniversität Ulmdc.publisher
LizenzStandard (Fassung vom 03.05.2003)dc.rights
Link zum Lizenztexthttps://oparu.uni-ulm.de/xmlui/license_v1dc.rights.uri
SchlagwortJanus Kinase 2dc.subject
SchlagwortMediastinal B-cell lymphoma (MBL)dc.subject
SchlagwortSignal transducers and activators of transcription (STAT)dc.subject
SchlagwortSOCS-1 mutationsdc.subject
SchlagwortSuppressor of cytokine signalling (SOCS-1)dc.subject
DDC-SachgruppeDDC 610 / Medicine & healthdc.subject.ddc
TitelConstitutive activation of Jak2/STAT5-signalling pathway in MedB-1 cells due to deficient SOCS-1dc.title
RessourcentypDissertationdc.type
DOIhttp://dx.doi.org/10.18725/OPARU-573dc.identifier.doi
URNhttp://nbn-resolving.de/urn:nbn:de:bsz:289-vts-54068dc.identifier.urn
GNDB-Zell-Lymphomdc.subject.gnd
FakultätMedizinische Fakultätuulm.affiliationGeneral
Datum der Freischaltung2005-12-13T14:59:39Zuulm.freischaltungVTS
Peer-Reviewneinuulm.peerReview
Signatur DruckexemplarZ: J-H 10.921 ; W: W-H 8.868uulm.shelfmark
DCMI MedientypTextuulm.typeDCMI
VTS-ID5406uulm.vtsID
KategoriePublikationenuulm.category


Dateien zu dieser Ressource

Thumbnail

Das Dokument erscheint in:

Zur Kurzanzeige